AUTHOR
PUBLICATIONS BY HKNPCSG
AUTHOR
Pan D, Rong X, Chen D, Jiang J, Ng WT, Mai H, Li Y, Li H, Cai J, Cheng J, Xu Y, Chua MLK, Simone CB 2nd, Lattanzi S, Tang Y.EClinicalMedicine. 2022 Aug 12;52:101618.
PUBLICATIONS BY HKNPCSG
Mortality of early treatment for radiation-induced brain necrosis in head and neck cancer survivors: A multicentre, retrospective, registry-based cohort study.
AUTHOR
Ng WT, Choi CW, But B, Ngan RKC, Tung S, Cheng AC, Kwong DLW, Lu TX, Chan ATC, Yiu H, Lee S, Wong F, Yuen KT, Chappell RJ, Lee AWM.Clin Cancer Res. 2022 Jun 13;28(12):2679-2689.
PUBLICATIONS BY HKNPCSG
Exploratory Study of NPC-0501 Trial: Optimal Cisplatin Dose of Concurrent and Induction/Adjuvant Chemotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma.
AUTHOR
Pan D, Rong X, Zhu Y, Ng WT, Chen D, Li H, Xu Y, Tang Y; Radiation Oncology Palliative Care Collaborative Group.Radiother Oncol. 2022 Mar;168:121-129.
PUBLICATIONS BY HKNPCSG
A novel nomogram to predict overall survival in head and neck cancer survivors with radiation-induced brain necrosis.
AUTHOR
Yip PL, Lee SF, Choi CH, Chan PS, Cheung KA, Chow CJ, Cheung KM, Lai WJ, Lee HV, Lam KO, Chiang CL, Wong CE, Poon MD, Tong M, Au KH, Ng WT, Ngan KR, Lee WA, Tung YS. Cancers (Basel). 2021 Aug 25;13(17):4286. doi: 10.3390/cancers13174286.
PUBLICATIONS BY HKNPCSG
External Validation of a Nomogram to Predict Survival and Benefit of Concurrent Chemoradiation for Stage II Nasopharyngeal Carcinoma.
AUTHOR
Chow JCH, Tam AHP, Cheung KM, Lee VHF, Chiang CL, Tong M, Wong ECY, Cheung AKW, Chan SPC, Lai JWY, Ngan RKC, Ng WT, Lee AWM, Au KH. Oral Oncol. 2020 Dec;111:105012. doi: 10.1016/j.oraloncology.2020.105012. Epub 2020 Sep 24.
PUBLICATIONS BY HKNPCSG
Second primary cancer after intensity-modulated radiotherapy for nasopharyngeal carcinoma: A territory-wide study by HKNPCSG.
AUTHOR
Head Neck, 2019
PUBLICATIONS BY HKNPCSG
Patterns of care and treatment outcomes for local recurrence of NPC after definite IMRT - A study by the HKNPCSG.
AUTHOR
Head Neck, 2019
PUBLICATIONS BY HKNPCSG
Dose Volume Effects of Re-irradiation for Locally Recurrent Nasopharyngeal Carcinoma.
AUTHOR
IJROBP, 2018
PUBLICATIONS BY HKNPCSG
Prospective, Multicenter, Phase 2 Trial of Induction Chemotherapy Followed by Bio-Chemoradiotherapy for Locally Advanced Recurrent Nasopharyngeal Carcinoma.
AUTHOR
IJROBP, 2018
PUBLICATIONS BY HKNPCSG
Concurrent-Adjuvant Chemoradiation Therapy for Stage III-IVB Nasopharyngeal Carcinoma-Exploration for Achieving Optimal 10-Year Therapeutic Ratio.